Business Intelligence

Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.

statue justice legal verdict malpractice case lawsuit scale

Congressional candidate physician sues hospital and doctor for death of father

Some of the claims in the lawsuit, brought against Novant Health by Kyle Horton, MD, are backed by a report from the North Carolina Department of Health and Human Services. 

Artificial intelligence AI

Industry Watcher’s Digest

HHS isn’t waiting to see what its incoming secretary does before filling some key leadership positions. 

Healthcare salaries and compensation

FTC, DOJ and HHS release report warning of private equity consolidation in healthcare

The agencies said private equity firms are rolling up healthcare sectors through serialized purchases that fly under the radar of regulators, creating an unsustainable level of consolidation. 

Thumbnail

Report highlights flaws in FDA rapid approval of Alzheimer drug

A new report from the Office of the Inspector General found the FDA failed to properly record meetings with drug manufacturers, ultimately approving drugs later shown to have safety and efficacy issues. 

telemedicine lawsuit new jersey

Telehealth diabetes management offering now part of Amazon marketplace

The integration was announced during the annual JP Morgan Health Care Conference in San Francisco. The program works through Amazon Benefits Manager to remotely help patients with weight and blood pressure management. 

Muppets and Sesame Street Characters

Sesame Street is coming to NewYork-Presbyterian Hospital

The partnership begins with a video series called “Ask a Doctor” featuring clinicians from the health system alongside Muppet characters. 

circuit board

Industry Watcher’s Digest

Having released the latest version of Llama in December, Meta is telling the world that open-source AI is the future of AI in healthcare. 

johnson & johnson branding

Johnson & Johnson buys depression drug and its manufacturer for $15B

The drug Caplyta, owned by Intra-Cellular Therapies, is being used to treat bipolar disorder and schizophrenia. In 2024, it brought in more than $481 million in sales.